Revive Therapeutics Ltd. (RVV)
CSE
Closed
Aug 24, 2026
Day's Range
0.025052 wk Range
0.00500Overview - RVV - Revive Therapeutics Ltd.
Key Statistics
Valuation
Enterprise Value
10.95M
P/E (Trailing)
‪-0.83‬
Price / Book
‪-2.70‬
EV / EBITDA
‪-8.40‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-16.44%‬
Return on Equity
‪-1,108.41%‬
Ownership
Shares Outstanding
435.67M
Float
429.35M
Held by Insiders
‪1.51%‬
Held by Institutions
‪0.0020%‬
Price stats
Beta
‪-1.85‬
50-Day Avg
‪0.0287‬
200-Day Avg
‪0.0247‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - RVV - Revive Therapeutics Ltd.
Peers - RVV - Revive Therapeutics Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on CSE.
Profile Summary - RVV - Revive Therapeutics Ltd.
About
Revive Therapeutics Ltd. is a life sciences company engaged in the research and development of novel therapies and technologies aimed at addressing unmet medical needs. The company primarily focuses on rare disorders and infectious diseases, undertaking initiatives to develop and improve existing treatments through…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
